MannKind Corporation Logo

MannKind Corporation

MNKD

(2.0)
Stock Price

6,85 USD

2.66% ROA

-9.46% ROE

150.28x PER

Market Cap.

1.776.467.700,00 USD

-106.6% DER

0% Yield

8.07% NPM

MannKind Corporation Stock Analysis

MannKind Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

MannKind Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (25.59%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (-3.87x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-147%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 ROA

The stock's ROA (-20.69%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-8) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

MannKind Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

MannKind Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

MannKind Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

MannKind Corporation Revenue
Year Revenue Growth
2000 154.000
2001 326.000 52.76%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 100.000 100%
2007 10.000 -900%
2008 20.000 50%
2009 0 0%
2010 93.000 100%
2011 50.000 -86%
2012 35.000 -42.86%
2013 0 0%
2014 0 0%
2015 0 0%
2016 174.758.000 100%
2017 11.745.000 -1387.94%
2018 27.859.000 57.84%
2019 63.038.000 55.81%
2020 65.144.000 3.23%
2021 75.442.000 13.65%
2022 99.770.000 24.38%
2023 205.012.000 51.33%
2023 198.962.000 -3.04%
2024 289.544.000 31.28%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

MannKind Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2000 20.542.000
2001 19.763.000 -3.94%
2002 42.724.000 53.74%
2003 45.613.000 6.33%
2004 59.266.000 23.04%
2005 95.347.000 37.84%
2006 191.796.000 50.29%
2007 256.844.000 25.33%
2008 250.442.000 -2.56%
2009 156.331.000 -60.2%
2010 112.279.000 -39.23%
2011 99.959.000 -12.33%
2012 101.522.000 1.54%
2013 109.719.000 7.47%
2014 100.244.000 -9.45%
2015 29.674.000 -237.82%
2016 14.917.000 -98.93%
2017 14.118.000 -5.66%
2018 8.737.000 -61.59%
2019 6.900.000 -26.62%
2020 6.248.000 -10.44%
2021 12.312.000 49.25%
2022 19.721.000 37.57%
2023 39.956.000 50.64%
2023 31.283.000 -27.72%
2024 47.264.000 33.81%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

MannKind Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2000 0
2001 0 0%
2002 0 0%
2003 0 0%
2004 17.883.000 100%
2005 22.775.000 21.48%
2006 42.001.000 45.78%
2007 50.523.000 16.87%
2008 55.343.000 8.71%
2009 53.447.000 -3.55%
2010 40.312.000 -32.58%
2011 40.630.000 0.78%
2012 45.473.000 10.65%
2013 59.682.000 23.81%
2014 79.383.000 24.82%
2015 108.402.000 26.77%
2016 27.074.000 -300.39%
2017 74.959.000 63.88%
2018 79.716.000 5.97%
2019 0 0%
2020 22.878.000 100%
2021 31.889.000 28.26%
2022 37.720.000 15.46%
2023 42.152.000 10.51%
2023 42.538.000 0.91%
2024 50.468.000 15.71%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

MannKind Corporation EBITDA
Year EBITDA Growth
2000 -25.446.000
2001 289.000 8904.84%
2002 -51.354.000 100.56%
2003 -58.630.000 12.41%
2004 -70.196.000 16.48%
2005 -110.809.000 36.65%
2006 -225.388.000 50.84%
2007 -298.187.000 24.41%
2008 -300.636.000 0.81%
2009 -209.708.000 -43.36%
2010 -151.773.000 -38.17%
2011 -140.521.000 -8.01%
2012 -148.144.000 5.15%
2013 -170.028.000 12.87%
2014 -177.939.000 4.45%
2015 -202.859.000 12.28%
2016 64.574.000 414.15%
2017 -94.039.000 168.67%
2018 -78.142.000 -20.34%
2019 -46.439.000 -68.27%
2020 -24.595.000 -88.81%
2021 -53.610.000 54.12%
2022 -66.510.000 19.4%
2023 25.552.000 360.29%
2023 16.395.000 -55.85%
2024 72.444.000 77.37%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

MannKind Corporation Gross Profit
Year Gross Profit Growth
2000 154.000
2001 326.000 52.76%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 100.000 100%
2007 10.000 -900%
2008 20.000 50%
2009 0 0%
2010 93.000 100%
2011 50.000 -86%
2012 35.000 -42.86%
2013 0 0%
2014 0 0%
2015 -140.412.000 100%
2016 124.666.000 212.63%
2017 -5.483.000 2373.68%
2018 7.380.000 174.3%
2019 35.059.000 78.95%
2020 40.503.000 13.44%
2021 36.585.000 -10.71%
2022 42.273.000 13.46%
2023 147.996.000 71.44%
2023 136.191.000 -8.67%
2024 208.036.000 34.53%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

MannKind Corporation Net Profit
Year Net Profit Growth
2000 -24.661.000
2001 -48.245.000 48.88%
2002 -206.265.000 76.61%
2003 -65.879.000 -213.1%
2004 -75.992.000 13.31%
2005 -114.338.000 33.54%
2006 -230.548.000 50.41%
2007 -293.190.000 21.37%
2008 -303.039.000 3.25%
2009 -220.104.000 -37.68%
2010 -170.560.000 -29.05%
2011 -160.804.000 -6.07%
2012 -169.366.000 5.06%
2013 -191.490.000 11.55%
2014 -198.382.000 3.47%
2015 -368.445.000 46.16%
2016 125.664.000 393.2%
2017 -117.333.000 207.1%
2018 -86.975.000 -34.9%
2019 -59.729.000 -45.62%
2020 -57.240.000 -4.35%
2021 -91.791.000 37.64%
2022 -112.169.000 18.17%
2023 6.884.000 1729.42%
2023 -11.938.000 157.66%
2024 -8.055.996 -48.19%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

MannKind Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2000 -20
2001 -23 13.64%
2002 -77 71.05%
2003 -18 -347.06%
2004 -15 -13.33%
2005 -14 -7.14%
2006 -23 36.36%
2007 -18 -22.22%
2008 -15 -28.57%
2009 -10 -40%
2010 -8 -42.86%
2011 -7 -16.67%
2012 -5 -50%
2013 -3 -33.33%
2014 -3 -50%
2015 -5 50%
2016 1 500%
2017 -1 200%
2018 -1 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

MannKind Corporation Free Cashflow
Year Free Cashflow Growth
2002 -82.814.000
2003 -57.954.000 -42.9%
2004 -66.806.000 13.25%
2005 -118.398.000 43.58%
2006 -210.567.000 43.77%
2007 -323.408.000 34.89%
2008 -353.741.000 8.57%
2009 -202.935.000 -74.31%
2010 -158.196.000 -28.28%
2011 -130.695.000 -21.04%
2012 -120.497.000 -8.46%
2013 -136.719.000 11.87%
2014 -20.011.000 -583.22%
2015 -67.517.000 70.36%
2016 -79.234.000 14.79%
2017 -64.778.000 -22.32%
2018 -38.085.000 -70.09%
2019 -91.048.000 58.17%
2020 -32.912.000 -176.64%
2021 -73.175.000 55.02%
2022 -88.268.000 17.1%
2023 -8.536.000 -934.07%
2023 -2.723.000 -213.48%
2024 759.000 458.76%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

MannKind Corporation Operating Cashflow
Year Operating Cashflow Growth
2002 -48.667.000
2003 -52.771.000 7.78%
2004 -59.911.000 11.92%
2005 -101.229.000 40.82%
2006 -189.794.000 46.66%
2007 -245.146.000 22.58%
2008 -271.288.000 9.64%
2009 -184.083.000 -47.37%
2010 -148.654.000 -23.83%
2011 -123.837.000 -20.04%
2012 -119.860.000 -3.32%
2013 -128.732.000 6.89%
2014 4.086.000 3250.56%
2015 -57.232.000 107.14%
2016 -78.090.000 26.71%
2017 -64.778.000 -20.55%
2018 -37.731.000 -71.68%
2019 -88.483.000 57.36%
2020 -28.128.000 -214.57%
2021 -61.709.000 54.42%
2022 -80.679.000 23.51%
2023 33.905.000 337.96%
2023 8.664.000 -291.33%
2024 3.731.000 -132.22%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

MannKind Corporation Capital Expenditure
Year Capital Expenditure Growth
2002 34.147.000
2003 5.183.000 -558.83%
2004 6.895.000 24.83%
2005 17.169.000 59.84%
2006 20.773.000 17.35%
2007 78.262.000 73.46%
2008 82.453.000 5.08%
2009 18.852.000 -337.37%
2010 9.542.000 -97.57%
2011 6.858.000 -39.14%
2012 637.000 -976.61%
2013 7.987.000 92.02%
2014 24.097.000 66.85%
2015 10.285.000 -134.29%
2016 1.144.000 -799.04%
2017 0 0%
2018 354.000 100%
2019 2.565.000 86.2%
2020 4.784.000 46.38%
2021 11.466.000 58.28%
2022 7.589.000 -51.09%
2023 42.441.000 82.12%
2023 11.387.000 -272.71%
2024 2.972.000 -283.14%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

MannKind Corporation Equity
Year Equity Growth
2000 31.890.000
2002 90.773.000 64.87%
2003 111.577.000 18.65%
2004 150.363.000 25.79%
2005 206.977.000 27.35%
2006 383.487.000 46.03%
2007 364.100.000 -5.32%
2008 86.734.000 -319.79%
2009 -59.221.000 246.46%
2010 -185.532.000 68.08%
2011 -313.652.000 40.85%
2012 -110.679.000 -183.39%
2013 -30.713.000 -260.37%
2014 -73.770.000 58.37%
2015 -350.334.000 78.94%
2016 -183.593.000 -90.82%
2017 -214.732.000 14.5%
2018 -175.082.000 -22.65%
2019 -190.526.000 8.11%
2020 -180.419.000 -5.6%
2021 -209.349.000 13.82%
2022 -250.538.000 16.44%
2023 -246.168.000 -1.78%
2023 -251.779.000 2.23%
2024 -225.780.000 -11.52%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

MannKind Corporation Assets
Year Assets Growth
2000 42.645.000
2002 104.773.000 59.3%
2003 125.876.000 16.76%
2004 163.483.000 23%
2005 228.371.000 28.41%
2006 539.737.000 57.69%
2007 543.443.000 0.68%
2008 282.459.000 -92.4%
2009 247.397.000 -14.17%
2010 277.256.000 10.77%
2011 199.553.000 -38.94%
2012 251.314.000 20.6%
2013 258.646.000 2.83%
2014 394.439.000 34.43%
2015 126.412.000 -212.03%
2016 107.063.000 -18.07%
2017 84.575.000 -26.59%
2018 107.705.000 21.48%
2019 93.725.000 -14.92%
2020 108.608.000 13.7%
2021 321.161.000 66.18%
2022 295.282.000 -8.76%
2023 475.198.000 37.86%
2023 320.328.000 -48.35%
2024 443.836.000 27.83%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

MannKind Corporation Liabilities
Year Liabilities Growth
2000 10.755.000
2002 14.000.000 23.18%
2003 14.299.000 2.09%
2004 13.120.000 -8.99%
2005 21.394.000 38.67%
2006 156.250.000 86.31%
2007 179.343.000 12.88%
2008 195.725.000 8.37%
2009 306.618.000 36.17%
2010 462.788.000 33.75%
2011 513.205.000 9.82%
2012 361.993.000 -41.77%
2013 289.359.000 -25.1%
2014 468.209.000 38.2%
2015 476.746.000 1.79%
2016 290.656.000 -64.02%
2017 299.307.000 2.89%
2018 282.787.000 -5.84%
2019 284.251.000 0.52%
2020 289.027.000 1.65%
2021 530.510.000 45.52%
2022 545.820.000 2.8%
2023 721.366.000 24.34%
2023 572.107.000 -26.09%
2024 669.616.000 14.56%

MannKind Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.91
Net Income per Share
0.04
Price to Earning Ratio
150.28x
Price To Sales Ratio
7.15x
POCF Ratio
43.42
PFCF Ratio
98.79
Price to Book Ratio
-7.81
EV to Sales
8.13
EV Over EBITDA
37.58
EV to Operating CashFlow
49.68
EV to FreeCashFlow
112.23
Earnings Yield
0.01
FreeCashFlow Yield
0.01
Market Cap
1,78 Bil.
Enterprise Value
2,02 Bil.
Graham Number
0.89
Graham NetNet
-1.43

Income Statement Metrics

Net Income per Share
0.04
Income Quality
3.46
ROE
-0.05
Return On Assets
0.05
Return On Capital Employed
0.14
Net Income per EBT
0.86
EBT Per Ebit
0.46
Ebit per Revenue
0.21
Effective Tax Rate
0.14

Margins

Sales, General, & Administrative to Revenue
0.17
Research & Developement to Revenue
0.17
Stock Based Compensation to Revenue
0.08
Gross Profit Margin
0.72
Operating Profit Margin
0.21
Pretax Profit Margin
0.09
Net Profit Margin
0.08

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.15
Free CashFlow per Share
0.07
Capex to Operating CashFlow
0.56
Capex to Revenue
0.09
Capex to Depreciation
3.36
Return on Invested Capital
1.4
Return on Tangible Assets
0.03
Days Sales Outstanding
35.48
Days Payables Outstanding
48.92
Days of Inventory on Hand
126.72
Receivables Turnover
10.29
Payables Turnover
7.46
Inventory Turnover
2.88
Capex per Share
0.08

Balance Sheet

Cash per Share
0,91
Book Value per Share
-0,83
Tangible Book Value per Share
-0.84
Shareholders Equity per Share
-0.83
Interest Debt per Share
1
Debt to Equity
-1.07
Debt to Assets
0.54
Net Debt to EBITDA
4.5
Current Ratio
4.07
Tangible Asset Value
-0,23 Bil.
Net Current Asset Value
-0,34 Bil.
Invested Capital
338109000
Working Capital
0,25 Bil.
Intangibles to Total Assets
0.01
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
25597500
Debt to Market Cap
0.14

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

MannKind Corporation Dividends
Year Dividends Growth

MannKind Corporation Profile

About MannKind Corporation

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

CEO
Dr. Michael E. Castagna Pharm.
Employee
411
Address
30930 Russell Ranch Road
Westlake Village, 91362

MannKind Corporation Executives & BODs

MannKind Corporation Executives & BODs
# Name Age
1 Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
70
2 Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
70
3 Dr. David B. Thomson J.D., Ph.D.
Executive Vice President, General Counsel & Secretary
70
4 Dr. Burkhard Blank M.D.
Executive Vice President of Research & Development and Chief Medical Officer
70
5 Ms. Rosabel Realica Alinaya CPA
Vice President of Investor Relations & Treasury
70
6 Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
70
7 Dr. Stuart A. Tross Ph.D.
Executive Vice President and Chief People & Workplace Officer
70
8 Mr. Christopher B. Prentiss M.B.A.
Chief Financial Officer
70
9 Ms. Lauren M. Sabella
Chief Operating Officer
70
10 Dr. Michael E. Castagna Pharm.D.
Chief Executive Officer & Director
70

MannKind Corporation Competitors